Literature DB >> 314368

The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients.

M G Bernengo, G Capella, A de Matteis, P A Tovo, G Zina.   

Abstract

The in vitro effect of a calf thymus extract (TP-1) on peripheral blood lymphocytes was evaluated in sixty-six melanoma patients. Twenty out of forty-five stage I and seventeen out of twenty-one stage IIb patients presented depressed T lymphocyte values. A statistically significant increase in E-rosette-forming cells (E-RFC) was observed in seventeen (85%) stage I and twelve (70.5%) stage II patients. In thirteen (65%) stage I and eight (47%) stage II patients E-RFC reached normal values. Our results indicate that the fall of T lymphocytes in the peripheral blood of melanoma patients is often related to an increase in TP-1 sensitive cells which suggests the possibility of a thymic hormone deficiency in these patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314368      PMCID: PMC1537716     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.

Authors:  A L Goldstein; G H Cohen; J L Rossio; G B Thurman; C N Brown; J T Ulrich
Journal:  Med Clin North Am       Date:  1976-05       Impact factor: 5.456

2.  Thymic hormone in T-cell maturation and classification of acute lymphocytic leukaemia.

Authors:  G Astaldi; U Topuz
Journal:  Boll Ist Sieroter Milan       Date:  1977-03-31

3.  Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone.

Authors:  J F Bach; M Dardenne; A L Goldstein; A Guha; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

4.  In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes.

Authors:  K Komuro; E A Boyse
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

5.  Inhibition of in vitro autosensitization by a thymic humoral factor.

Authors:  N Trainin; C Carnaud; D Ilfeld
Journal:  Nat New Biol       Date:  1973-10-24

6.  Relationship between T and B lymphocyte values and prognosis in malignant melanoma.

Authors:  M G Bernengo; G Capella; M Peruccio; G Zina
Journal:  Br J Dermatol       Date:  1978-06       Impact factor: 9.302

7.  Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes.

Authors:  P Lonai; B Mogilner; V Rotter; N Trainin
Journal:  Eur J Immunol       Date:  1973-01       Impact factor: 5.532

Review 8.  Primary immunodeficiency and malignancy.

Authors:  J H Kersey; B D Spector; R A Good
Journal:  Birth Defects Orig Artic Ser       Date:  1975

9.  Thymosin-induced reduction of "null cells" in peripheral-blood lymphocytes of patients with systemic lupus erythematosus.

Authors:  M A Scheinberg; E S Cathcart; A L Goldstein
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

10.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

View more
  2 in total

1.  Effect of a thymic factor, thymostimulin, on growth and pulmonary metastases of Lewis lung carcinoma.

Authors:  M Yagi; T Yamashita; E Tsubura
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

2.  Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. I. Reciprocal effect on T and B rosette formation.

Authors:  J Shoham; M Cohen; Y Chandali; A Avni
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.